166 related articles for article (PubMed ID: 9623285)
1. [Vaccination against hepatitis B in Switzerland: towards a global strategy].
Kammerlander R; Vaudaux B; Bourquin C; Zimmermann HP; Raeber PA
Rev Med Suisse Romande; 1998 Apr; 118(4):335-9. PubMed ID: 9623285
[No Abstract] [Full Text] [Related]
2. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
3. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B in Canada: the case for universal vaccination. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
CMAJ; 1992 Jan; 146(1):25-8. PubMed ID: 1530816
[No Abstract] [Full Text] [Related]
5. Global progress toward universal childhood hepatitis B vaccination, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
[TBL] [Abstract][Full Text] [Related]
6. Acute hepatitis B among children and adolescents--United States, 1990-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1015-8. PubMed ID: 15525899
[TBL] [Abstract][Full Text] [Related]
7. [Hepatitis B vaccination is still current].
Kremp O
Soins Pediatr Pueric; 1999; (187):31-2. PubMed ID: 10615148
[No Abstract] [Full Text] [Related]
8. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs.
Goldstein ST; Alter MJ; Williams IT; Moyer LA; Judson FN; Mottram K; Fleenor M; Ryder PL; Margolis HS
J Infect Dis; 2002 Mar; 185(6):713-9. PubMed ID: 11920288
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness and cost benefit of viral hepatitis B vaccination in the Slovak Republic.
Hudecková H; Straka S; Szilágyiová M; Avdicová M; Rusnáková S
Cent Eur J Public Health; 2002 Dec; 10(4):146-8. PubMed ID: 12528387
[TBL] [Abstract][Full Text] [Related]
11. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
12. A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?
Gervais A; Longuet P; Leport C
Clin Infect Dis; 2008 Mar; 46(6):876-7. PubMed ID: 18269331
[No Abstract] [Full Text] [Related]
13. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign.
Mele A; Mariano A; Tosti ME; Stroffolini T; Pizzuti R; Gallo G; Ragni P; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2007 Feb; 44(3):e17-24. PubMed ID: 17205431
[TBL] [Abstract][Full Text] [Related]
14. Critical issues surrounding hepatitis B vaccination for adolescents: a roundtable.
Brookman RR; Koff RS; Schaffner W; Margolis HS; Collins M; Bloom BS; Coupey SM
J Adolesc Health; 1995 Oct; 17(4):208-33. PubMed ID: 8580123
[No Abstract] [Full Text] [Related]
15. Universal hepatitis B vaccination: the economics of prevention.
Krahn MD; Detsky AS
CMAJ; 1992 Jan; 146(1):19-21. PubMed ID: 1530815
[No Abstract] [Full Text] [Related]
16. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
Mele A; Stroffolini T; Zanetti AR
J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
[TBL] [Abstract][Full Text] [Related]
17. Multiple sclerosis and vaccination against hepatitis B: analysis of risk benefit profile.
Tosti ME; Traversa G; Bianco E; Mele A
Ital J Gastroenterol Hepatol; 1999; 31(5):388-91. PubMed ID: 10470598
[TBL] [Abstract][Full Text] [Related]
18. [Strategies for universal vaccination against hepatitis B].
Pérez-Trallero E; Cilla G
Med Clin (Barc); 1995 Sep; 105(8):316. PubMed ID: 7475485
[No Abstract] [Full Text] [Related]
19. [Hepatitis B vaccination in 7th year students in Lausanne].
Woringer V
Rev Med Suisse Romande; 1999 Aug; 119(8):647-52. PubMed ID: 10489476
[No Abstract] [Full Text] [Related]
20. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
